Email this article 
Hide
Show all
Measuring performance of countries to face covid-19 threat and the role of low population and high level of helthcare expenditure to mitigate negative effects
Abstract
Abstract. The goal of study is to suggest the Index of resilience that detects which countries have had the best performance to reduce mortality related to COVID-19 pandemic and the Index of preparedness that assesses performance of countries to support COVID-19 vaccinations. The sample under study is European countries having a similar socioeconomic system. Results show that Iceland, Norway and Finland have a higher performance of resilience, reducing mortality in society, likely because a smaller size of population, whereas Belgium and Czech Republic the lowest performance. Instead, The UK has the highest performance to rollout vaccinations, driven by a high level of healthcare expenditure and the discovery and production of one of the COVID-19 vaccines. However, results suggest that manifold countries have low pandemic preparedness and several biological security weaknesses that have to be improved with and effective planning of crisis management for pandemic threats.
Keywords. Covid-19, Coronavirus infections, Crisis management, COVID-19 Mortality, Vaccination plans, Pandemic preparedness, Pandemic Responses, Healthcare expenditure, Population.
JEL. M15.Keywords
Full Text:
Zotero
MendeleyReferences
Abuza, Z. (2020). Explaining successful (and unsuccessful) COVID-19 responses in Southeast Asia. The Diplomat. Retrieved July 7. [Retrieved from]
Ackoff, R.L., & Rovin, S. (2003). Redesigning Society. Stanford University Press, Stanford
Anttiroiko, A.-V. (2021). Successful government responses to the pandemic: Contextualizing national and urban responses to the Covid-19 outbreak in East and West. International Journal of E-Planning Research, 10(2), 1-17.
Ardito, L., Coccia, M., Messeni, P.A. (2021). Technological exaptation and crisis management: Evidence from COVID-19 outbreaks. R&D Management, doi. 10.1111/radm.12455
Chang, S., Pierson, E., Koh, P.W. et al., (2020). Mobility network models of Covid-19 explain inequities and inform reopening, Nature, doi. 10.1038/s41586-020-2923-3
Coccia, M. (2019). A Theory of classification and evolution of technologies within a generalized Darwinism, Technology Analysis & Strategic Management, 31(5), 517-531. doi. 10.1080/09537325.2018.1523385
Coccia, M. (2015). Spatial relation between geo-climate zones and technological outputs to explain the evolution of technology. Int. J. Transitions and Innovation Systems, 4(1), 5-21. doi. 10.1504/IJTIS.2015.074642
Coccia, M., & Bellitto, M. (2018). Human progress and its socioeconomic effects in society, Journal of Economic and Social Thought, 5(2), 160-178. doi. 10.1453/jest.v5i2.1649
Coccia, M. (2017). Sources of disruptive technologies for industrial change. L’industria –Rivista di Economia e Politica Industriale, 38(1), 97-120. doi. 10.1430/87140
Coccia, M. (2018). The origins of the economics of Innovation, Journal of Economic and Social Thought, 5(1), 9-28. doi. 10.1453/jest.v5i1.1574
Coccia, M. (2019). Why do nations produce science advances and new technology? Technology in Society, 59, 101124, 1-9. doi. 10.1016/j.techsoc.2019.03.007
Coccia, M. (2019a). The theory of technological parasitism for the measurement of the evolution of technology and technological forecasting, Technological Forecasting and Social Change, 141, 289-304. doi. 10.1016/j.techfore.2018.12.012
Coccia, M., & Watts, J. (2020). A theory of the evolution of technology: technological parasitism and the implications for innovation management, Journal of Engineering and Technology Management, 55, 101552. doi. 10.1016/j.jengtecman.2019.11.003
Coccia, M. (2020a). Deep learning technology for improving cancer care in society: New directions in cancer imaging driven by artificial intelligence. Technology in Society, 60, 1-11. doi. 10.1016/j.techsoc.2019.101198
Coccia, M. (2020). Factors determining the diffusion of COVID-19 and suggested strategy to prevent future accelerated viral infectivity similar to COVID. Science of the Total Environment, 729, 138474. doi. 10.1016/j.scitotenv.2020.138474
Coccia, M. (2020b). How (un)sustainable environments are related to the diffusion of COVID-19: The relation between coronavirus disease 2019, air pollution, wind resource and energy. Sustainability, 12, 9709. doi. 10.3390/su12229709
Coccia, M. (2020a). An index to quantify environmental risk of exposure to future epidemics of the COVID-19 and similar viral agents: Theory and practice. Environmental Research, 191, 110155. doi. 10.1016/j.envres.2020.110155
Coccia, M. (2021). Effects of the spread of COVID-19 on public health of polluted cities: results of the first wave for explaining the dejà vu in the second wave of COVID-19 pandemic and epidemics of future vital agents. Environmental Science and Pollution Research 28(15), 19147-19154. doi. 10.1007/s11356-020-11662-7
Coccia, M. (2021b). The relation between length of lockdown, numbers of infected people and deaths of Covid-19, and economic growth of countries: Lessons learned to cope with future pandemics similar to Covid-19. Science of The Total Environment, 145801. doi. 10.1016/j.scitotenv.2021.145801
Coccia, M. (2021c). The effects of atmospheric stability with low wind speed and of air pollution on the accelerated transmission dynamics of COVID-19. International Journal of Environmental Studies, 78(1), 1-27. oi. 10.1080/00207233.2020.1802937
Coccia, M. (2021d). The impact of first and second wave of the COVID-19 pandemic: comparative analysis to support control measures to cope with negative effects of future infectious diseases in society. Environmental Research, 111099, doi. 10.1016/j.envres.2021.111099
Cylus, J., Pantel, D., & van Ginneken, E. (2021). Who should be vaccinated first? Comparing vaccine prioritization strategies in Israel and European countries using the Covid-19 Health System Response Monitor. Israel Journal of Health Policy Research, 10(1), 16.
DeRoo, S.S., Pudalov, N.J., & Fu, L.Y. (2020). Planning for a COVID-19 vaccination program. JAMA, 323(24), 2458–2459. doi. 10.1001/jama.2020.8711
Dooling, K., McClung, N., & Chamberland, M. et al. (2020). The advisory committee on immunization practices’ interim recommendation for allocating initial supplies of covid-19 vaccine—United States, MMWR Morb Mortal Wkly Rep, 69, 1857–1859.
Ethgen, O., Rémy, V., & Wargo, K. (2018). Vaccination budget in Europe: an update. Human vaccines & Immunotherrapeutics, 14(12), 2911–2915. doi. 10.1080/21645515.2018.1504528
European Centre for Disease Prevention and Control, (2021). Data on hospital and ICU admission rates and current occupancy for COVID-19. Accessed March 2021. [Retrieved from].
Eurostat 2021. Population on 1 January – total. accessed March 2021. [Retrieved from].
Evans, S., & Bahrami, H. (2020). Super-flexibility in practice: Insights from a crisis. Global Journal of Flexible Systems Management, 21(3), 207-214.
Faes, C., Abrams, S., Van Beckhoven, D., Meyfroidt, G., Vlieghe, E., Hens, & N., Belgian Collaborative Group on COVID-19 Hospital Surveillance. (2020). Time between symptom onset, Hospitalisation and recovery or death: Statistical analysis of Belgian COVID-19 patients. Int. J. Environ. Res. Public Health, 17, 7560.
Frankel, J. (2012). What small countries can teach, World. Bus Econ, 47, 97–103. doi. 10.1057/be.2012.7
Frederiksen, L., Zhang, Y., Foged, C., & Thakur, A. (2020). The long road toward COVID-19 herd immunity: Vaccine platform technologies and mass immunization strategies. Frontiers in Immunology, 11, 1817. doi. 10.3389/fimmu.2020.01817
Freed, G.L. (2021). Actionable lessons for the US COVID vaccine program. Israel Journal of Health Policy Research, 10(1), 14. doi. 10.1186/s13584-021-00452-2
Glatman-Freedman, A., Cohen, M.L., Nichols, K.A., Porges, R.F., Saludes, I.R., Steffens, K. Rodwin, V.G., & Britt, D.W. (2010). Factors affecting the introduction of new vaccines to poor nations: a comparative study of the Haemophilus influenzae type B and hepatitis B vaccines. PloS One, 5(11), e13802.
Glatman-Freedman, A., & Nichols, K. (2012). The effect of social determinants on immunization programs. Human Vaccines & Immunotherapeutics, 8(3), 293–301. doi. 10.4161/hv.19003
GOV.UK (2021) Coronavirus (COVID-19) in the UK. accessed 28 March 2021. [Retrieved from].
Harrison, E.A., & Wu, J.W. (2020). Vaccine confidence in the time of COVID-19. European Journal of Epidemiology, 35(4), 325–330. doi. 10.1007/s10654-020-00634-3
Janssen, M., & van der Voort, H. (2020). Agile and adaptive governance in crisis response: Lessons from the COVID-19 pandemic. International Journal of Information Management, 55, Article number.102180.
Johns Hopkins Center for System Science and Engineering, (2021). Coronavirus COVID-19 global cases. accessed in 4 January 2021. [Retrieved from].
Kluge, H.H.P., Nitzan, D., & Azzopardi-Muscat, N. (2020). COVID-19: reflecting on experience and anticipating the next steps. A perspective from the WHO regional office for Europe. Eurohealth, 26(2), 156-168.
Lab 24 (2021). Il vaccino anti covid in Italia in tempo reale | Il Sole 24 ORE. accessed March 2021. [Retrieved from].
Lau, H., Khosrawipour, T., Kocbach, P., Ichii, H., Bania, J., & Khosrawipour, V. (2021). Evaluating the massive underreporting and undertesting of COVID-19 cases in multiple global epicenters. Pulmonology, 27(2), 110–115. doi. 10.1016/j.pulmoe.2020.05.015
Lowy Institute, (2021). COVID Performance Index- deconstructuring pandemic responses. Accessed March 2021. [Retrieved from].
Mendonça, D, & Fiedrich, F. (2006) Training for improvisation in emergency management: opportunities and limits for information technology. Int J Emerg Manag, 3(4), 348–363.
Milner, C., & Weyman–Jones, T. (2003). Relative national efficiency and country size: Evidence for developing countries, Review of Development Economics, 7(1), 1-14.
Mulino, D. (2005). Welfare, population growth and dynamic inefficiency in an OLG framework, Monash Economics Working Papers, No.19/05.
National Academy of Medicine, (2021). Advancing pandemic and seasonal influenza vaccine preparedness and response. Harnessing lessons from the efforts mitigating the COVID-19 pandemic. accessed 9 March 2021. [Retrieved from].
National Academy of Medicine, (2021a). Advancing pandemic and seasonal influenza Vaccine preparedness and response. accessed March 2020. [Retrieved from].
NHS, (2021). Coronavirus (COVID-19) vaccine, Accessed 28 March 2021. [Retrieved from].
Oliver, S., Gargano, J., & Marin, M. et al. (2020). The advisory committee on immunization practices’ interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine — United States, MMWR Morb Mortal Wkly Rep, 69, 1922-1924. doi. 10.15585/mmwr.mm6950e2external
Our World in Data, (2021). Coronavirus (COVID-19) vaccinations - statistics and research - our World in data. Accessed March 2020. [Retrieved from].
Pagliaro, M., & Coccia, M. (2021). How self-determination of scholars outclasses shrinking public research lab budgets, supporting scientific production: a case study and R&D management implications. Heliyon. 7(1), e05998. doi. 10.1016/j.heliyon.2021.e05998
Presidenza del Consiglio dei Ministri, (2021). Report vaccini anti COVID-19, governo Italiano - Report Vaccini Anti Covid-19. accessed march 2021. [Retrieved from].
Renardy, M., Eisenberg, M., & Kirschner, D. (2020). Predicting the second wave of COVID-19 in washtenaw county, MI, Journal of Theoretical Biology, 507, Article number.110461. doi. 10.1016/j.jtbi.2020.110461
Ritchie, H., Ortiz-Ospina, E., Beltekian, D., Mathieu, E., Hasel, J., Macdonald, B., Giattino, C., & Roser, M. (2020). Policy responses to the coronavirus pandemic. Our World in data, statistics and research. Retrieved July 7. [Retrieved from].
Sagan, A., Thomas, S., McKee, M., Karanikolos, M., Azzopardi-Muscat, N., de la Mata, I., & Figueras, J. (2020). COVID-19 and health systems resilience: lessons going forwards, Eurohealth 2020; 26(2).
Sharkansky, I., & Zalmanovitch, Y. (2000) Improvisation in public administration and policy making in Israel. Public Adm Rev, 60(4), 321–329.
Shi, H., Gazal, S., & Kanai, M. et al. (2021). Population-specific causal disease effect sizes in functionally important regions impacted by selection. Nat Commun 12, 1098(2021). doi. 10.1038/s41467-021-21286-1c
U.S. Department of Health & Human Services, (2021). Public health emergency-executive summary. accessed March 2021. [Retrieved from].
Williams, G.A., Ulla Díez, S.M., Figueras, J., & Lessof, S. (2020). Translating evidence into policy during the covid-19 pandemic: bridging science and policy (and politics). Eurohealth 2020; 26(2).
World Bank, (2021). Current health expenditure (% of GDP), Accessed March 2021. [Retrieved from].
Worldwide Governance Indicators, (2021). The Worldwide Governance Indicators (WGI) project. accessed 26 March 2021. [Retrieved from].DOI: http://dx.doi.org/10.1453/jsas.v8i4.2266
Refbacks
- There are currently no refbacks.
....................................................................................................................................................................................................................................................................................................................................... Journal of Social and Administrative Sciences - J. Adm. Soc. Sci. - JSAS - www.kspjournals.org
ISSN: 2149-0406
Editor: editor-jsas@kspjournals.org Secretarial: secretarial@kspjournals.org Istanbul - Turkey.
Copyright © KSP Library
